Clinical Trials Browser

Phase 1 × Lymphoma × tositumomab I-131 × Clear all

NCT00434629 2016-08-17

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant

Phase 1 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell